Ignite Creation Date:
2024-05-05 @ 5:23 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00448097
Status:
TERMINATED
Last Update Posted:
2016-03-17
First Post:
2007-03-14
Brief Title:
Efficacy and Safety Study of Cetuximab or Cetuximab Plus Docetaxel to Treat Prostate Cancer Before Prostatectomy
Sponsor:
The Methodist Hospital Research Institute
Organization:
The Methodist Hospital Research Institute
Organization Data
Organization:
The Methodist Hospital Research Institute
Class:
OTHER
Study ID:
HMRI IRB0206-0027
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
The Methodist Hospital Research Institute
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Eli Lilly and Company | INDUSTRY |
| Bristol-Myers Squibb | INDUSTRY |